US Patent 11753461 Optimized factor VIII genes
Patent 11753461 was granted and assigned to Bioverativ on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+32 properties)
Article (+474 characters)
US Patent 11753461 Optimized factor VIII genes
Article
The present disclosure provides codon optimized Factor VIII sequences, vectors, and host cells comprising codon optimized Factor VIII sequences, polypeptides encoded by codon optimized Factor VIII sequences, and methods of producing such polypeptides. The present disclosure also provides methods of treating bleeding disorders such as hemophilia comprising administering to the subject a codon optimized Factor VIII nucleic acid sequence or the polypeptide encoded thereby.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11753461
Patent Inventor Names
Siyuan Tan
Tongyao Liu
Date of Patent
September 12, 2023
Patent Application Number
16074729
Date Filed
January 31, 2017
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11753461 Optimized factor VIII genes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
